[Treatment of chronic collagen diseases using cytostatics].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002908:Chronic Disease; D003095:Collagen Diseases / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D014228:Triaziquone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D011239:Prednisolone; D014228:Triaziquone
Behandlung chronischer Bindegewebserkrankungen mit Zytostatika.